This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
What is CILICANT’s vision for the future of active pharma packaging, and how do you see it contributing to the overall goals of the pharma industry? Active packaging does more than maintain stability; it empowers the pharma industry to deliver medications that are safer and more effective.
In turn, it enhances patient engagement and experience at optimal cost [5] Strengthening digital infrastructure and adopting advanced methods to collect, analyse and implement data are essential [6] Smart pharma packaging has made progress, but there is still a long way to go.
Lawmakers agreed to extend telehealth flexibilities, fund public health programs, and enact these major PBM changes as part of a government funding package they are planning to pass before the end of the year, according to four health care industry sources and two congressional aides.
Gerresheimer, a systems and solutions provider for the pharmaceutical and biotech industry, has introduced a web-based product database designed to streamline the selection and registration of primary plastic packaging for medicinal products. It is constantly updated with new content and functionality to meet current and future needs.”
The ADAPT X feeder is designed to accommodate complex and unconventional tablet shapes, providing flexibility for diverse packaging requirements. Additionally, the feeder features tool-less changeovers and precise product placement to reduce downtime and improve packaging efficiency. High-speed operation: Offers speeds of up to 13.2
The language of the government funding package has not been publicly released as of Monday night and could still change, but sources indicate some longtime health care policy priorities are making the cut for the year-end spending deal, Rachel Cohrs Zhang reports.
Bringing together over 225+ exhibitors and showcasing 12000+ products and solutions, the expo will represent diverse industries, including pharmaceutical manufacturing, biotechnology, medical devices and diagnostics, cosmeceuticals, nutraceuticals, packaging solutions, and healthcare IT.
Product packaging has undergone major changes and now focuses on building sustainable capabilities to avoid dependence on eco-friendly materials. Meanwhile, companies are exploring eco-friendly solutions like energy-efficient refrigerants and sustainable packaging.
4,5,6 However, these benefits are contingent on the ability to generate comprehensive, high-quality analytical and PK data packages. 10 The package, once adopted, is expected to introduce changes to regulatory exclusivity, market access, and competition rules for medicines, including biosimilars, across the EU.
Packaging materials must be developed and innovated with a strong sustainability perspective [4] Regulatory frameworks should be established to mandate the use of sustainable materials [5] The e-pharmacy sector is growing rapidly, but its reliance on non-biodegradable materials poses challenges.
This challenges us to rethink how products are made, assembled, and packaged. Flexibility offers freedom within certain boundaries, but adaptive manufacturing removes those boundaries entirely.
SCHOTT Pharma announced that it has added a Knowledge Hub to its Pharmaversity, which was established in 2020 as a pharmaceutical educational initiative to provide industry professionals, academics and other stakeholders with insights into cutting-edge pharma trends, topics, and specialised pharmaceutical packaging solutions.
Almost 120,000 packs of Boots Paracetamol have been recalled because of a packaging error where they are incorrectly labelled as Aspirin on the foil blister.
ACG’s unique value lies in our holistic approach to the pharma industry, a journey that started 60 years ago with capsules and has since expanded to include everything from filling machines and packaging to advanced supply chain technology like the Life Sciences Cloud. The answer is all of the above.
A new government proposal to display nutritional labels on the front of food packaging is aimed at helping Americans make more informed choices about what they eat. An eventual side effect, research and expert commentary suggests, could be nudging the food industry to make healthier food, too.
The company is also investing ₹4–5 crore in automating its packaging operations. In a recent move, Kashmik launched Dapagliflozin under the DAPNEC brand in the anti-diabetic segment. The product is priced up to 400 per cent lower than comparable brands in the market.
Outcome: Post-remediation reviews showed reduced complaint rates and improved QA oversight of packaging operations. Validation was extended to cover stability samples and simulated shipping conditions, with defined triggers for revalidation. Regulatory concerns were closed without further escalation.
and Europe held manufacturers accountable for their environmental impact, leading to an increase in partnerships with tech companies focused on sustainable packaging and production solutions. Regulatory bodies in the U.S. Finally, reshoring and localised production emerged as key strategies for improving supply chain resilience.
Jayakumar gave examples of common issues, such as packaging damage or consistency problems in ointments, stressing the importance of not dismissing seemingly minor complaints, as they could escalate into more significant quality issues.
ICH Q6B for Analytics Richard Easton ; Christopher Ziegenfuss June 6th 2025 Article ICH Q6B provides expectations and a clear framework for the structural characterization of biopharmaceutical products.
In the third part of her Pharma Commerce video interview, Kirsten Newquist, Identiv’s CEO, shares the ways in which regulations, including DSCSA, are impacting the adoption of smarter packaging technologies across the industry.
At the same time, the sector holds significant ESG opportunities, especially in renewable energy use, ethical supply chain practices, circular packaging models, and expanded reach through schemes like Ayushman Bharat and Jan Aushadhi. These risks were laid bare during the pandemic and continue to affect service delivery and public trust.
We also see a growing emphasis on sustainable practices in manufacturing and packaging, aligning with global trends in reducing carbon footprint and waste. In addition, the nutra market boom in APAC that began during the COVID-19 pandemic continues to accelerate looking for green-label, plant-based capsules for encapsulation.
The committee recommended that the combination should not be used in children below the age of four years and advised that manufacturers must include the warning: “fixed dose combination shall not be used in children below four years of age” on the product label, package insert, and any promotional literature.
In an article published here ten days back, I provided a detailed account of a most worrying case where counterfeiters succeeded in acquiring batch-specific serial numbers of Sun Pharmas anti-epileptic drug Levipil 500, which were then embedded into QR codes on fake packages. Sun Pharma needs to flip that switch off right away.
The site will have a variety of manufacturing capabilities, including preparation, filling, assembly and packaging, in addition to quality control (QC) laboratories. The new high-tech facility will produce both existing and upcoming biosimilar medicines in Sandoz’s portfolio. “… With a commitment of over $1.1
He also discussed the importance of having retention samples for raw materials and packaging materials and the role of quality control in investigating deviations and ensuring the stability of raw materials. He mentioned the necessity of having license number, and manufacturer address on certificates of analysis.
The event brought together 46 delegates representing 17 companies from the authentication, packaging, and brand protection industries. The agenda was moderated by Kaunain Shahidi, Packaging and Sustainability Expert. The session began with an address from Manoj Kochar, President of ASPA.
Sectors Sections Clinical Trials Drug Manufacturers Therapy Area Pricing and Market Access Latest Bayer’s Eylea market grip set to slip as Alvotech biosimilar closes in Harbour BioMed partners Otsuka on new T-cell therapy Madrigal poised to enter European MASH market after CHMP endorsement Themes Sections Artificial Intelligence Cloud Corporate Governance (..)
Innovations in packaging, electric delivery fleets, and IoT-driven inventory systems are making online pharmacies more efficient and eco-friendly. Sustainability and Innovation: The Next Chapter Reports from Juniper Research and Statista suggest that sustainability and automation will be key themes over the next decade.
– Be alert to damaged packages. Some important handling and storage rules include: – Store starting materials clean, dry, and if necessary, cold. – Store starting materials off the ground and under cover. – Always keep containers sealed when not in use. – Never use dirty or wet sampling or measuring equipment.
Sectors Sections Clinical Trials Drug Manufacturers Therapy Area Pricing and Market Access Latest Zambon gains Chinese regulatory authority approval for Fluimucil IV Navamedic signs agreement to acquire dne pharma Hims & Hers shares plummet 35% as Novo Nordisk pulls partnership plug Themes Sections Artificial Intelligence Cloud Corporate Governance (..)
Most Popular Biopharma is on edge about NIH funding cuts and what the future holds for research After myriad failures, a new wave of ALS drugs approaches CDC panel, newly remade by RFK Jr.,
Experts praise the reforms to rare disease and antimicrobial research, but they worry that some provisions in the EU Pharma Package may harm innovation on the continent, contrary to its stated objectives. In a bid to chase competitiveness, the EU is advancing its most drastic revision of pharmaceutical law in 20 years.
1,3 According to the package insert for Gammagard Liquid ERC, it is contraindicated in patients with severe systemic hypersensitivity or anaphylactic reactions to the product.
What we've done is blend PillPack's innovative packaging with Amazon Pharmacy's user-friendly approach and affordability, so these patients can now get their medications in convenient, personalized packets and order everything online through our digital pharmacy.
The company focuses on utilising packaging to minimise end-of-life waste and employs distribution methods that further reduce environmental impact. Downstream Activities (Scope 3) Lonza has designed optimised distribution networks to reduce transport distances to customers, ensuring efficient logistics with a lower carbon footprint.
Sometimes we exclude medications from our protocol, various CYP enzymes and kind of going through a package insert to see, should we exclude this drug or not? And even just 10 minutes ago before we got on the call, I was looking up a drug. So there’s still definitely a lot of PharmD in there.
This article explores why E&L studies go wrong and how to build a submission-ready package from protocol to final report. Most projects fail not in the lab, but in study design, regulatory interpretation, and documentation.
It's cognitive behavioral therapy packaged as a digital experience. I've even seen VR experiences, so it can be packaged in any type of digital experience. Areo Nazari, PharmD: PDTs are digital or software-based treatments that are approved by the FDA to treat disease.
Along with the successful pivotal trials, Launch-HTN and Advance-HTN, and the ongoing open-label extension trial, these results comprise the core package for our planned NDA submission.” “Explore-CKD established that lorundrostat 25 mg once daily has a favorable clinical profile for this patient population.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content